Section des Unités de recherche. Evaluation report. Research unit : Functional Genomics of Solid Tumors. Of University Paris 5
|
|
- Alannah Shaw
- 2 years ago
- Views:
Transcription
1 Section des Unités de recherche Evaluation report Research unit : Functional Genomics of Solid Tumors Of University Paris 5 March 2009
2 Section des Unités de recherche Evaluation report Research unit : Functional Genomics of Solid Tumors Of University Paris 5 March
3 Evaluation report The research unit : Name of the research unit : Functional Genomics of Solid Tumors Requested label : UMR_S INSERM N in case of renewal : UMR_S 674 Head of the research unit : Ms. J. Zucman-Rossi University or school : University Paris 5 Other institutions and research organization: INSERM Date of the visit : March 6th
4 Members of the visiting committee Chairman of the commitee : M. Claude SARDET, CNRS, IGMM UMR 5535, Montpellier Other committee members : M. Philippe MERLE, INSERM U871, CHU Lyon M.Jean-François DUFOUR, Klinische pharmakologie, Berne, Switzerland M. A. KANE, Brown University, pathology and medicine laboratory, Providence, USA M.Massimo LEVRERO, Sapienza University of Rome, Italy M. Eamonn MAHER, Medical genetics, University of Birmingham, UK CNU, CoCNRS, CSS INSERM, représentant INRA, INRIA, IRD..) representatives : M. Philippe MONTCOURRIER, CSS, INSERM M. Bernard DUCOMMUN, CNU Observers AERES scientific representative: M. Charles DUMONTET University or school representative: M. Bruno VARET, Université Paris 5 Mme Marie-Claude LABASTIE, Université Paris 5 Research organization representatives : Ms. Chantal LASSERE, INSERM Ms. Danielle MURCIANO, INCA 4
5 Evaluation report 1 Short presentation of the research unit Number of lab members: 20 including o 2 researchers o 4 researchers with teaching duties: 3 PU-PH, 1MCU o 1 PH o 3 post-doctoral fellows o 5 PhD students, all with a fellowship o 6 engineers and technicians: 2 IE, 1 TS, and 3AI on short term contracts Number of HDR : 5, 4 of them being PhD student advisors Number of students who have obtained their PhD during the past 4 years: 5 Number of lab members who have been granted a PEDR : 0 Number of publishing lab members : 6 out of 6 2 Preparation and execution of the visit The present unit is composed of two teams: the team working on neurofibromatosis (NF) tumors and development was not evaluated here since the team leader recently moved to California to create a new lab One should regret that France lost this bright scientist with unique expertises in animal models. The remaining team members working on meothelioma chose to merge with the other team to, collectively, present a new project. They will be joined by clinicians from the HEGP and from Necker hospital working on Renal Cancer. The review took place at the present site of implantation of the unit (St-Louis Hospital). Oral presentations of the research program were made by senior and junior scientists, as well as by clinicians, participating in the new project. These presentations have described the highlights of the past three years achievements of the three groups and outlined the ongoing and future research directions of the new unit. The review group met the students / post-doc, the technical staff and the representative of the Paris 5 University, Inserm and INCA. All members of the review group were present from the beginning to the end of this visit and have returned independently their argumented comments to the chairman. 3 Overall appreciation of the activity of the research unit, of its links with local, national and international partners The research unit is currently located at Centre Hayem/ Hopital St-Louis/Paris7. It was composed of two teams working on various cellular, molecular, developmental and genetic aspects of neurofibromatosis (NF, team 1), mesothelioma and of liver cancers (team 2), respectively. In 2007, the leader of team 1 moved to California to develop his projects on NF and was replaced by the current project leader as head of this unit. Team 1 members working on mesothelioma choose to merge with team 2 to, collectively, present a new «one team» project. Overall, this unit appears as a highly interactive team of basic and clinical researchers whose goal is to identify new diagnostic and prognostic molecular markers of liver cancer and mesothelioma using genomic profiling as well as functional studies. They do so by driving collaborative networks throughout France to use very valuable tumor banks with complete clinical and pathological correlations. 5
6 Their attempt to work closely with internationally-recognized pathologists and epidemiologists is a major strength and unique in genomic approaches to solid tumors. Recent progress in the genomic analysis of these solid tumors has been most successful for liver tumors, with slower progress for malignant mesothelioma. Notably, the liver tumor team has achieved significant progress during the last four years in identifying novel candidate tumor suppressors and oncogenes and by developing a new molecular classification for hepatic adenomas with significant implications for targeted therapy. Collectively, scientists and clinicians involved in this project have an outstanding publication record, a long list of invitations to the best international scientific meetings, and overall have recently greatly contributed to the development of research on cancers (see section 4 below for details). This places this unit in excellent position to increase in size during the next four years and to apply the same successfull strategy to other types of tumors, starting with mesothlioma. In addition, a group of clinicians from the HEGP and from Necker working on Renal Cancer, is willing to join the unit as soon as possible to benefit from its genomic profiling expertise, and is therefore considered as being part of the new project. The combination of the currently available genomics expertise and the clinical trials expertise in kidney cancer provides great potential for translational studies to identify molecular markers for prognostication and choice of therapy. In general, the evolution of this team to include closer collaboration with active clinical researchers and to further improve interactions between basic and translational researchers is a major strength and is essential for achieving their future goals. In summary, this project will include three sub-groups which envision the same line of research on cancers of various origins. The successfull strategy used by the project leader in liver tumors will be used as a matrix for future studies on mesothelioma and renal cancers. To fulfill these collective and ambitious scientific objectives, the unit wishes to move to an other campus offering a better context for projects targeting solid tumors and aiming to combine genetic, bioinformatic and biological approaches. Additional space and resources would allow them to grow and recruit younger scientists to build a critical mass of basic cancer researchers. Accordingly, they are currently responding to a 2009 call made by Institut Cochin/University Paris 5 to attract additional research units working on cancer on the Cochin campus. Undoubtedly, the technological platforms and interdisciplinary laboratories present in this prestigious Institute fit perfectly with the scientific objectives of this project and should enable this team to incorporate a more functional approach into their genomic analyses. The University representative confirmed that the university actively supports this operation, notably, through the creation of a full professor position (PU-PH) proposed to the project leader. Overall, this appears to the review committee as an excellent scientific operation for both parts. 4 Specific appreciation team by team This team will includes three sub-groups that vision the following lines of research : Liver Tumors: This group has been outstandingly successful in using genetic approaches to the classification of hepatic tumours. Their work has provided the rare combination of both important insights into the basic biology of neoplastic processes and clinically-relevant molecular markers for the prognostic stratification and diagnostic classification of benign hepatic tumours. This work is clearly outstanding and has changed in a few years the way one looks at benign and malignant liver cancers. This work also led to the identification of mutations in novel signaling pathways involved in tumorigenesis. This work have been published widely in the most competitive and prestigious peer-reviewed journals (Nature, Hepatology, J Hepatology, Gut, Cancer Research) and the group is the driving force in many excellent ongoing collaborative networks. Their future projects are along the same line and will try to bring further functional and translational validations of the importance of these pathways in cancer, while they tackle other sub-types of liver cancers. This project is scientifically excellent and timely since it is clear that the incidence of liver cancers is increasing and it has been recently shown that targeted therapies interfering with signalling pathways improves the survival of patients with liver carcinomas. Nevertheless, on the genomic aspect of this program, the review group encourages this unit to pay more attention to how newer technologies (e.g. second generation sequencing) might be utilised for the proposed studies. 6
7 Collectively, this group appears well organised, harmonious and attractive, i.e. in a good position to recruit new scientists and clinicians around its thematic and to foster new fruitful collaborations. Indeed, the committee estimates that there is an urgent need to attract additional scientists with permanent and nonpermanent positions to fully exploit the numerous and exciting opportunities presented, as well as to perpetuate their very valuable expertises in the long term. Notably, a biostatistician / bioinformatician would be a great asset to the unit. Mesothelioma : The incidence of mesothlioma is rapidly increasing in France and although it is considered as newsworthy, too few groups are working in this field. Noteworthy, this is one of the rare labs in France that has made several important contributions in this field : i/ They have established key collaborations throughout France that led to the constitution of a very valuable tumor bank with complete clinical and pathological correlations. This attempt to work closely with internationally-recognized pathologists and epidemiologists is a major strength and unique in genomic approaches to malignant mesothelioma. Their project is now at the stage to utilise this very valuable ressource to apply a similar approach to that employed by the liver group to define the transcriptional profile and genome copy number characteristics of mesothelioma. Although they were careful not to overinterpret preliminary and unpublished data, there were hints during the on-site visit that this strategy has already provided novel information. The visiting committee strongly encourages this group to pursue its efforts in this direction since it is anticipated that any novel information on the pathways altered in mesothelioma should give the group visibility in the arena of cancer biology and should open urgently needed new directions for biological, classification and clinical studies on this cancer. ii/ They also established one of the rare animal models that develop mesothelioma. Some aspects of this project (complex KO models) are suffering from the departure of team 1, and although advances have been made with these animals it might become difficult to go further in this direction since the headcount devoted to this topic appears at present too restricted to develop this type of long-term project in a competitive way. The review group encourages the team to freeze/slow down temporarily its studies on such models while waiting for additional information on signaling pathways altered in mesothelioma. Since the very competent scientific leader of this group is due to retire during the next mandate of the unit, this project is clearly and urgently in need of a younger scientist who could offer long-term leadership on the experimental aspects of this project and bridge the gap between the clinicians and the technical and nonpermanent staff. Renal cancers : A group of clinicians from the HEGP and from Necker working on Renal Cancer is willing to join this unit. The leader of this group has experience of both clinical and laboratory based research on prostate and Renal cancers. As a clinical investigator he has been prolific with several publications in the highest impact factor journals describing the results of clinical trials (N Engl J Med, J Clin Oncol, Clin Cancer Res). These achievements attest to his ability to organize patient recruitment and specimen procurement. A very large number of kidney cancer (RCC) samples from patients treated with anti-angiogenic agents are currently available for analysis and a large prospective collection has been initiated. There is here an excellent opportunity to use similar approaches to those adopted for the liver tumor studies in order to identify prognostic markers of response to angiogenic therapies for advanced RCC. This is a very important clinical question and accurate biomarkers for the identification of patients likely to respond to treatment with very expensive therapies would be a major advance. The review group strongly support this project as it estimates that it is timely and represents an important strategic opportunity for the future unit, the combined expertises placing this team in good position, worldwide, to contribute unique results to translational research on RCC. Our only concern about this project is that the planned headcount of scientists devoted to this topic appears too limited to develop rapidly in a competitive way. A strong and immediate effort of the unit to recruit highquality, young scientists to work on this project is necessary. 5 Appreciation of resources and of the life of the research unit There are no causes for concern in the current direction and management of the personnel and resources. Most participants to this project have an excellent track record in attracting competitive private and public external fundings. The principal investigator of the Unit is to be congratulated. 7
8 She is an energetic and imaginative leader, and a productive scientist, who has the support of team members at all levels and gets the most out of her staff. This unit appears well organised, harmonious and seems to work in a pleasant friendly atmosphere. The training and support for graduate students and postdoctoral fellows is excellent. In summary, the project leader has all the leadership qualities and she and her co-applicants appear to be keen to work together and develop and expand this new unit. The arrival of a group working on renal cell cancer is a very positive step that should reinforce the translational research expertise and clinical visibility of the unit. However, concerning future projects, the effort to recruit high-quality, young scientists to this team to expand their capacity for the proposed experimental studies must be intensified and accelerated or there will be a risk to lose this momentum and leadership in genomics of solid tumors. This will require additional support from the «tutelle» (INSERM/University/INCA) to obtain additional lab-space, scientific staff (MCU?) and financial resources, possibly through its installation within a larger research center such as Cochin Institute. 6 Recommendations and advice Strong points: Overall, this is an excellent, timely and forward looking application from a team that is in the best worldwide position to contribute unique results to the field of solid tumors. As so, this project justifies funding and full support from participating institutions. Weak points: The number of full time researchers is low when considering the number of ambitious projects planned. Recommendations: The committee recommends to identify space and resources as soon as possible to move this research team close to a larger research center with modern core research facilities and platforms, and broader biological expertises. The committee recommends to appoint several permanent and non-permanent younger scientists that would bridge the gap between the well-established applicants, the clinicians and the remaining staff, i.e. develop a strategy to sustain interactions of the physician-scientists working on these research projects. This point is urgent for the mesothelioma and RCC projects that have great potential but will require stronger investment in manpower (scientists) to fully achieve the opportunities presented. A permanent biostatistician / bioinformatician would be a great asset to most parts of this project. Inserm/University/Inca should provide additional support on this question. On the technological/genomic aspects of this program, the review group encourages this unit to pay more attention to how newer technologies (e.g. second generation sequencing) might be used for the proposed studies. Note de l unité Qualité scientifique et production Rayonnement et attractivité, intégration dans l environnement Stratégie, gouvernance et vie du laboratoire Appréciation du projet A+ A+ A+ A+ A+ 8
9
10
Report from the visiting commitee
Section des Unités de recherche Report from the visiting commitee Research unit: Biothérapies hépatiques University of Nantes January 2008 Section des Unités de recherche Report from the visiting committee
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Génomique, bioinformatique et applications From the Conservatoire National des Arts et Métiers (CNAM) Mai 2010 Section des Unités de recherche
Report from the visiting committee
Section des Unités de recherche Report from the visiting committee Research unit : Cancer Immunotherapy University Paris 5 March 2008 Section des Unités de recherche Report from the visiting committee
Section des Unités de recherche. Evaluation report. Research unit : Génétique humaine des maladies infectieuses. University Paris 5
Section des Unités de recherche Evaluation report Research unit : Génétique humaine des maladies infectieuses University Paris 5 March 2009 Section des Unités de recherche Evaluation report Research unit
Section des Unités de recherche. Evaluation report. Research unit : Génétique moléculaire évolutive et médicale. of the University Paris 5
Section des Unités de recherche Evaluation report Research unit : Génétique moléculaire évolutive et médicale. of the University Paris 5 March 2009 Section des Unités de recherche Evaluation report Research
Section des Unités de recherche. Evaluation report. Research unit Ecosystème Intestinal, Probiotiques, Antibiotiques. University Paris 5
Section des Unités de recherche Evaluation report Research unit Ecosystème Intestinal, Probiotiques, Antibiotiques University Paris 5 February 2009 Section des Unités de recherche Evaluation report Research
HCERES report on research unit: Under the supervision of the following institutions and research bodies: Biology of Cancer and Infection BCI
Research units HCERES report on research unit: Biology of Cancer and Infection BCI Under the supervision of the following institutions and research bodies: Université Joseph Fourier - Grenoble - UJF Institut
Section des Unités de recherche. Evaluation report. Research unit : Troubles du comportement alimentaire de l adolescent. University Paris 11
Section des Unités de recherche Evaluation report Research unit : Troubles du comportement alimentaire de l adolescent University Paris 11 Mars 2009 Section des Unités de recherche Rapport d'évaluation
University Versailles-Saint-Quentin en Yvelines
Section des Unités de recherche Evaluation report Research unit Pathophysiology and Clinical Pharmacology of Pain University Versailles-Saint-Quentin en Yvelines March 2009 Section des Unités de recherche
HCERES report on research unit:
Research units HCERES report on research unit: Actions for oncogenesis understanding and Target Identification in ONcology ACTION Under the supervision of the following institutions and research bodies:
Section des Unités de recherche. Evaluation report. Research unit Biochimie Bactérienne. AgroParisTech
Section des Unités de recherche Evaluation report Research unit Biochimie Bactérienne AgroParisTech March 2009 Section des Unités de recherche Evaluation report Research unit Biochimie Bactérienne AgroParisTech
Ecole Normale Supérieure (ENS)
Section des Unités de recherche Evaluation report Research unit: Laboratoire de Physique Théorique (LPT ENS) UMR 8549 Ecole Normale Supérieure (ENS) March 2009 Section des Unités de recherche Evaluation
HCERES report on research unit: Under the supervision of the following institutions and research bodies:
Research units HCERES report on research unit: Pathophysioloy, Diagnosis and Treatments of Bone Diseases LYOS Under the supervision of the following institutions and research bodies: Université Claude
HCERES report on research unit: Under the supervision of the following institutions and research bodies:
Research units HCERES report on research unit: Cellules Stromales, Homeostasie, Plasticité et Regénération Tissulaire STROMALab Under the supervision of the following institutions and research bodies:
HCERES report on research unit:
Research units HCERES report on research unit: Translational Gene Therapy for neuromuscular and retinal diseases Under the supervision of the following institutions and research bodies: Université de Nantes
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Neuroinflammation : imaging and therapy of multiple sclerosis From the Université Bordeaux 2 Victor Segalen INSERM (for the project) May
From the Ecole Nationale Vétérinaire de Maison Alfort UMR INRA 1198
Section des Unités de recherche Evaluation report Research unit : Biologie du Développement et de la Reproduction From the Ecole Nationale Vétérinaire de Maison Alfort UMR INRA 1198 March 2009 Section
Report from the visiting committee
Section des Unités de recherche Report from the visiting committee Research unit : Therapy of striated muscles disorders University of Paris 6 April 2008 Section des Unités de recherche Report from the
Section des Unités de recherche. Evaluation report. Research unit : Cellular homeostasis and cancer. University Paris 5
Section des Unités de recherche Evaluation report Research unit : Cellular homeostasis and cancer University Paris 5 Mars 2009 Section des Unités de recherche Evaluation report Research unit : Cellular
Ecole Nationale Véterinaire d Alfort
Section des Unités de recherche Evaluation Report Research unit: Biomécanique et Pathologie Locomotrice du Cheval (BPLC) Ecole Nationale Véterinaire d Alfort Mars 2009 Section des Unités de recherche Evaluation
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Hypoxia, Patho-Physiology From the University Grenoble 1 INSERM May 2010 Section des Unités de recherche AERES report on the research unit
Necker-Enfants Malades hospital
Necker-Enfants Malades hospital 1 NECKER AND THE UNIVERSITY 2 Université Paris Descartes Psychologie Sciences humaines IUT Droit Pharmacie Odontologie Saints-Pères Médecine School of Medicine of Paris-Descartes
Research units. Laboratory of Microbial Molecular Genetics LMGM
Research units HCERES report on research unit: Laboratory of Microbial Molecular Genetics LMGM Under the supervision of the following institutions and research bodies: Université Toulouse 3 - Paul Sabatier
DIVISION OF LIVER DISEASES
The Liver Disease Fellowship at Mount Sinai is the largest program of its kind in the United States. DIVISION OF LIVER DISEASES DR. SCOTT FRIEDMAN serves on the governing board of the American Association
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Center for Human Immunology From the Pasteur Institute May 2010 Section des Unités de recherche AERES report on the research unit Center
2016 POST-DOCTORAL PROGRAM Applicant Guide
2016 POST-DOCTORAL PROGRAM Applicant Guide POST-DOCTORAL FELLOWSHIP PROGRAM 2016 Applicant guide The Initiative of Excellence of the University of Bordeaux (IdEx Bordeaux) is opening positions for postdoctoral
Section des Unités de recherche. Evaluation Report. Research unit : Food allergy laboratory INRA
Section des Unités de recherche Evaluation Report Research unit : Food allergy laboratory INRA March 2009 2 Section des Unités de recherche Evaluation report Research unit : Food allergy laboratory INRA
Report from the visiting committee
Section des Unités de recherche Report from the visiting committee Research unit : Cancer Virotherapy UMR_S 701 University Louis Pasteur - Strasbourg 1 February 2008 Section des Unités de recherche Report
Future Directions in Cancer Research What does is mean for medical physicists and AAPM?
Future Directions in Cancer Research What does is mean for medical physicists and AAPM? John D. Hazle, Ph.D., FAAPM, FACR President-elect American Association of Physicists in Medicine Professor and Chairman
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Pathologies of the Nervous System: Epidemiological and Clinical Research From the University of Montpellier 1 INSERM Mai 2010 Section des
Report from the visiting committee
Section des Unités de recherche Report from the visiting committee Research unit: Laboratoire de Chimie et Biochimie des Complexes Moléculaires (LCBCM) - UMR 7576 Ecole Nationale Supérieure de Chimie de
Under the supervision of the following institutions and research bodies:
Research units HCERES report on unit: Fruit Biology and Pathology BFP Under the supervision of the following institutions and research bodies: Institut National de la Recherche Agronomique - INRA Université
LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH
LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH FUNDING OPPORTUNITY DESCRIPTION 2016 REQUEST FOR APPLICATION (RFA) Lung Cancer Foundation of America (LCFA) and the International
AERES report on the Federative Research Structure:
Section des Unités de recherche AERES report on the Federative Research Structure: Cell and Tissue Engineering From the: Université de Franche-Comté March 2011 Section des Unités de recherche AERES report
HCERES report on research unit: Under the supervision of the following institutions and research bodies: Host Pathogens Interactions IHAP
Research units HCERES report on research unit: Host Pathogens Interactions IHAP Under the supervision of the following institutions and research bodies: Institut National de la Recherche Agronomique -
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Fonction structure et inactivation d ARN bactériens From the University Rennes 1 INSERM December 2010 Section des Unités de recherche AERES
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
HCERES report on the federation: Under the supervision of the following institutions and research bodies:
Research units HCERES report on the federation: Fédération de Recherche Lasers et Plasmas Under the supervision of the following institutions and research bodies: Université de Bordeaux Université Paris-Sud
Kentucky Lung Cancer Research Program. 2010 Strategic Plan Update
Kentucky Lung Cancer Research Program 2010 Strategic Plan Update Approved by the KLCR Program Governance Board August 12, 2009 KLCR Program Strategic Plan Table of Contents Introduction... 3 GOAL 1: Investigator-Initiated
HCERES report on research unit: Under the supervision of the following institutions and research bodies: Department of immunology
Research units HCERES report on research unit: Department of immunology Under the supervision of the following institutions and research bodies: Institut Pasteur Paris Institut National de la Santé Et
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Nutrition, Growth and Cancer From the University François-Rabelais INSERM January 2011 Section des Unités de recherche AERES report on
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
Griffith University - Case for Support. Mesothelioma Research Program
Griffith University - Case for Support Mesothelioma Research Program Professor Lyn Griffiths Director, Dean, Research and Director, Genomics Research Centre (GHI) Established in 2007. Integrated health
Funding Opportunities Starter Grants
Funding Opportunities Starter Grants Marc R. Moon, M.D. Joseph C. Bancroft Professor of Surgery Division of Cardiothoracic Surgery & Center for Diseases of the Thoracic Aorta Washington University School
HCERES report on research unit: Under the supervision of the following institutions and research bodies:
Research units HCERES report on research unit: Cancer Research Center of Toulouse CRCT Under the supervision of the following institutions and research bodies: Université Toulouse 3 Paul Sabatier Centre
HCERES report on research unit: Under the supervision of the following institutions and research bodies: Targeted Therapies in Oncology
Research units HCERES report on research unit: Targeted Therapies in Oncology Under the supervision of the following institutions and research bodies: Université Claude Bernard Lyon 1 - UCB Université
New Investigators. 2012 report
New Investigators 2012 report Summary Cancer Research UK has a strong portfolio of fellowships to support new researchers at the start of their independent careers. We currently support our new investigators
Career Opportunities within the French Alliance for Life and Health Sciences
1 Career Opportunities within the French Alliance for Life and Health Sciences Mireille Guyader, PhD Director, Inserm-USA Office INSERM KEY FIGURES (Year 2013) Budget: 970 M (~ $1.2 Billion) Human resources:
What do Birmingham postgraduates do?
1 Essential information What do Birmingham postgraduates do? School of First destinations of postgraduates Analysis of first employment destinations of postgraduates from the College of Medical and Dental
Pathologist s Discussion of Plaintiffs Latest Theories
Pathologist s Discussion of Plaintiffs Latest Theories Mary Beth Beasley, MD Mt. Sinai Medical Center Annenberg Building 15th Floor Room 50 1468 Madison Avenue New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
A Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific
Molecular Biotechnology Master s Degree Program
> APPLIED LIFE SCIENCES Master s Degree Program: > FULL TIME Molecular Biotechnology Master s Degree Program www.fh-campuswien.ac.at My Occupational Future. Your Career Opportunities Biotechnology is one
CLINICAL DEPARTMENTS STATEMENT OF FACULTY ORGANIZATION, STANDARDS AND CRITERIA FOR RANK (Approved 9/27/94) (Revised 10/13/04, 12/20/05, 12/2007)
CLINICAL DEPARTMENTS STATEMENT OF FACULTY ORGANIZATION, STANDARDS AND CRITERIA FOR RANK (Approved 9/27/94) (Revised 10/13/04, 12/20/05, 12/2007) INTRODUCTION Each Clinical Department 1 will develop the
How Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS
Ushering in a new era of cancer medicine Center is ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized in our laboratories and our clinics.
Call 2014: High throughput screening of therapeutic molecules and rare diseases
Call 2014: High throughput screening of therapeutic molecules and rare diseases The second call High throughput screening of therapeutic molecules and rare diseases launched by the French Foundation for
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Modélisation Conceptuelle des Connaissances Biomédicales From the Université de Rennes 1 INSERM December 2010 Section des Unités de recherche
Of the University Paris 11, CEA, Collège de France, INSERM
Section des Unités de recherche Evaluation report Research unit : Imagerie en psychiatrie Of the University Paris 11, CEA, Collège de France, INSERM March 2009 Section des Unités de recherche Rapport d'évaluation
Department of Animal, Dairy and Veterinary Science Mid-Term Graduate Review of 5-Year Plan December 31, 2014. Program description:
Department of Animal, Dairy and Veterinary Science Mid-Term Graduate Review of 5-Year Plan December 31, 2014 Program description: The Department of Animal, Dairy, and Veterinary Sciences (ADVS) offers
The NIH Roadmap: Re-Engineering the Clinical Research Enterprise
NIH BACKGROUNDER National Institutes of Health The NIH Roadmap: Re-Engineering the Clinical Research Enterprise Clinical research is the linchpin of the nation s biomedical research enterprise. Before
Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D.
Pier Paolo Di Fiore M.D. Ph.D. Curriculum Vitae Education 1981 - M.D., summa cum laude, University of Naples, 2nd Medical School, Naples, Italy 1984 - Board in Oncology, summa cum laude, University of
Admissions...713/500-5116 Alumni Relations...713/500-5065 Continuing Medical Education...713/500-5249 Educational Programs...
fact book The University of Texas Health Science Center at Houston in the Texas Medic I-45 59 Lyndon B. Johnson Gen Hospital I-10 I-10 Rice University Campus Downtown Houston 59 Texas Medical Center I-45
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes
ISSN 2154-4006 The Genetic Basis of Human Disease zbar Colloquium series on Series Editor: Michael Dean, Ph.D., Head, Human Genetics Section, Senior Investigator, Laboratory of Experimental Immunology
UPBM CURRICULAR BROCHURE
UPBM CURRICULAR BROCHURE Undergraduate Program in Biology and Medicine Contents Academic Year 2015-16 About the Undergraduate Program in Biology and Medicine...pg. 1 Undergraduate Majors...pg. 2-3 Getting
Graduate Fellowships. Preparing the leaders of tomorrow. school of medicine. The Campaign for Washington University
Graduate Fellowships Preparing the leaders of tomorrow school of medicine The Campaign for Washington University Together, we change lives. Washington University educates and trains outstanding scientists
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
Resumen Curricular de los Profesores. Jesse Boehm
Resumen Curricular de los Profesores Jesse Boehm Jesse Boehm is the assistant director of the Cancer Program at the Broad Institute. In this role, he works closely with Cancer Program director Todd Golub
MD/Ph.D. Degree Requirements
COMBINED MD/Ph.D. DEGREE REQUIREMENTS MD/Ph.D. Program Eligibility Application to the Program General Requirements of the Program T he combined MD/Ph.D. degree program at the University of Toledo offers
Institut Curie Co-fund PhD program IC-3i-PhD
Institut Curie Co-fund PhD program IC-3i-PhD Institut Curie Hospital group Research Center Private foundation, created in 1909 accepting public donations A leading player in the fight against cancer Institutional
Rapport de l AERES sur la structure fédérative :
Section des Unités de recherche Rapport de l AERES sur la structure fédérative : Fédération de Recherche Laser Plasma - FR2707 sous tutelle des établissements et organismes : Université Bordeaux 1 CNRS
The University of Texas Health Science Center at San Antonio Tobacco Funds Budget Fiscal Year Ending August 31, 2015
Permanent Health Funds for Higher Education (Fund 810) Permanent Health Funds will be assigned to schools to support health education, research programs, and infrastructure operations. Strategy F.1.2.,
Evaluation report. of the Cochin Institute University Paris 5. Research unit : Department of Cellular Biology and Host-Pathogen Interactions
Section des Unités de recherche Evaluation report Research unit : Department of Cellular Biology and Host-Pathogen Interactions of the Cochin Institute University Paris 5 March 2009 Section des Unités
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements
Fiscal Year 2013 (FY13) Prostate Cancer Research Program (PCRP) Reference Table of Award Mechanisms and Submission Requirements PCRP AWARD MECHANISMS WITH EMPHASIS ON RESOURCES Clinical Consortium Award
IBCSG Tissue Bank Policy
THE INTERNATIONAL BREAST CANCER STUDY GROUP IBCSG Tissue Bank Policy Accepted by the IBCSG Executive Committee on March 24, 2006 Accepted by the IBCSG Ethics Committee on March 24, 2006 Accepted by the
Straight from the Horse s Mouth: Mentors, Mentees & Recruiters Tell All about Careers for Epidemiologists
Straight from the Horse s Mouth: Mentors, Mentees & Recruiters Tell All about Careers for Epidemiologists U.S. Government: Combining Research, Mentoring & Service Work Martha S. Linet, M.D., MPH Workshop
Master of Science in BIOINFORMATICS. > information. > insight. > innovation
Master of Science in BIOINFORMATICS > information > insight > innovation The Program Master of Science in Bioinformatics The College of Science at Northeastern University is committed to delivering cutting-edge
Technology funding opportunities at the National Cancer Institute
Technology funding opportunities at the National Cancer Institute Through the Cancer Diagnosis Program http://cancerdiagnosis.nci.nih.gov/index.html Avraham Rasooly Ph.D. National Cancer Institute, Cancer
mixomics: a software for researchers to analyse large data sets
mixomics: a software for researchers to analyse large data sets The University of Queensland Diamantina Institute Brisbane, Australia Systems biology Systems biology is the study of complex interactions
Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma
The Use of Kinase Inhibitors: Translational Lab Results Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma Sheelu Varghese, Ph.D. H. Richard Alexander, M.D.
Master of Science in Biochemistry (Molecular Medicine Option).
Master of Science in Biochemistry (Molecular Medicine Option). Molecular medicine is a specialized area of medicine. Its main thrust is to understand the molecular and cellular basis of disease. Understanding
University of Medicine and Dentistry of New Jersey (UMDNJ)
University of Medicine and Dentistry of New Jersey (UMDNJ) Dual-Degree Program between the UMDNJ Graduate School of Biomedical Sciences (GSBS) And the UMDNJ School of Public Health (SPH) Leading to the:
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
Regulatory Issues in Genetic Testing and Targeted Drug Development
Regulatory Issues in Genetic Testing and Targeted Drug Development Janet Woodcock, M.D. Deputy Commissioner for Operations Food and Drug Administration October 12, 2006 Genetic and Genomic Tests are Types
M.S. DEGREE REQUIREMENTS
Graduate Group in Biochemistry, Molecular, Cellular & Developmental Biology Ph.D. and M.S. DEGREE REQUIREMENTS Graduate Council Approval: April 15, 2009 MASTER'S PROGRAM 1) Admissions Requirements Applicants
AERES report on the research unit
Section des Unités de recherche AERES report on the research unit Centre Lasers Intenses et Applications (CELIA) UMR 5107 From the Université Bordeaux 1 CNRS CEA/DSM May 2010 Section des Unités de recherche
Page 1 of 5. Preamble:
Page 1 of 5 Report from the External Review Team, which reviewed the Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School July 22-23, 2010. Members of the External Review team:
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Report from the visiting committee
Section des Unités de recherche Report from the visiting committee Research unit : Centre de Mathématiques Appliquées (CMAP) UMR 7641 Ecole Polytechnique February 2008 Section des Unités de recherche Report
exactly. The need for efficiency in developing effective new therapeutics has never been greater.
exactly. The need for efficiency in developing effective new therapeutics has never been greater. As demands on the global healthcare system increase and treating disease becomes more complex, the research,
Translocation Renal Cell Carcinomas: Molecular insights and Future Directions
Translocation Renal Cell Carcinomas: Molecular insights and Future Directions Gabriel G. Malouf, MD, PhD Assistant professor Department of medical oncology Pitié-Salpêtrière Hospital, Paris, France Background
Statement for the Record for the September 25, 2008, hearing entitled, Cell Phone Use and Tumors: What the Science Says
Statement for the Record for the Subcommittee on Domestic Policy Committee on Oversight and Government Reform United States House of Representatives Statement for the Record for the September 25, 2008,
EMBL. International PhD Training. Mikko Taipale, PhD Whitehead Institute/MIT Cambridge, MA USA
EMBL International PhD Training Mikko Taipale, PhD Whitehead Institute/MIT Cambridge, MA USA Why create an EMBL? The structure of DNA had been solved and first protein structures were being identified
Master Online Study Program @dvanced Oncology. Study part time team up internationally!
Master Online Study Program @dvanced Oncology Study part time team up internationally! Ulm University is developing an innovative international postgraduate study program @dvanced Oncology addressing clinical
DEPARTMENT OF RADIOLOGY UNIVERSITY OF MINNESOTA MEDICAL SCHOOL. RESEARCH TRACK (W) STATEMENT Promotion Criteria and Standards
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL RESEARCH TRACK (W) STATEMENT Promotion Criteria and Standards PART 1. MEDICAL SCHOOL PREAMBLE I. INTRODUCTORY STATEMENT This document describes the specific criteria
Journée des Industriels du Réseau TRIGGERSEP
Journée des Industriels du Réseau TRIGGERSEP Djillali ANNANE Hôpital Raymond Poincaré (AP-HP) Lab Cell Death Inflamation & Infection UMR1173 UVSQ/INSERM Mercredi 3 juin 2015 Institut Pasteur Paris Expertise:
Creating the Future Pierre and Marie Curie University. www.upmc.fr
Creating the Future Pierre and Marie Curie University www.upmc.fr UPMC: the Leading French Scientific and Medical University Every day, UPMC demonstrates how education and research create important synergies.
Section des Unités de recherche. Evaluation report. Research unit : Human tumor immunology. University Paris 11
Section des Unités de recherche Evaluation report Research unit : Human tumor immunology University Paris 11 Mars 2009 Section des Unités de recherche Evaluation report Research unit : Human tumor immunology
TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES
CALL TEXT TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES Submission deadline of proposals: 30 th of January 2015 at 01 p.m. CET (Paris, Berlin local time) Link to Call for Proposals